Bajaj HealthCare Limited (BOM:539872)
India · Delayed Price · Currency is INR 334.10
+2.40 (0.72%)
At close: Sep 11, 2026
Bajaj HealthCare Market Cap
Bajaj HealthCare has a market cap or net worth of 11.25 billion as of September 11, 2026. Its market cap has decreased by -16.68% in one year.
Market Cap
11.25B
Enterprise Value
13.36B
Revenue
6.28B
Ranking
n/a
PE Ratio
46.66
Stock Price
334.10
ChartMarket Cap Chart
Since May 10, 2016, Bajaj HealthCare's market cap has increased from 1.16B to 11.25B, an increase of 871.53%. That is a compound annual growth rate of 24.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 11.25B | -14.25% |
| Dec 31, 2025 | 13.11B | -27.72% |
| Dec 31, 2024 | 18.14B | 74.95% |
| Dec 29, 2023 | 10.37B | -15.46% |
| Dec 30, 2022 | 12.27B | 7.73% |
| Dec 31, 2021 | 11.39B | 85.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Symbiotec Pharmalab | 72.85B |
| IOL Chemicals and Pharmaceuticals | 61.57B |
| Gujarat Themis Biosyn | 56.13B |
| NGL Fine-Chem | 17.09B |
| Shree Ganesh Remedies | 8.55B |
| Influx Healthtech | 6.43B |
| Aarey Drugs & Pharmaceuticals | 2.84B |
| Accretion Nutraveda | 2.04B |